Clinical Trials Browser

Phase 1/2 × Lymphoma × glofitamab × Clear all

NCT05896163 2025-10-20

MAPtivate-6

Phase 1/2 Active not recruiting

Lymphoma, Recurrence, Lymphoma, Large B-Cell, Diffuse